Eugeroics (originally, "eugrégorique" or "eugregoric"),[1] also known as wakefulness-promoting agents and wakefulness-promoting drugs, are a class of drugs that promote wakefulness and alertness.[2][3] They are used medically for the treatment of certain sleeping disorders, such as excessive daytime sleepiness and narcolepsy.[2][3] They generally have a very low addictive potential.[2][3]

Drug class
The chemical structure of modafinil, the prototypical drug of this class.
Class identifiers
Synonymswakefulness-promoting agent
wakefulness-promoting drug
UsePromote wakefulness and alertness
ATC codeN06B
In Wikidata

The prototypical eugeroic is modafinil; other drugs in the class include adrafinil and armodafinil. Modafinil and armodafinil have been found to act as selective, weak, atypical dopamine reuptake inhibitors.[2][3]




Never marketed

In Development

See also


<a href='/wiki/Category:Drug_classes_defined_by_psychological_effects' title='Category:Drug classes defined by psychological effects'>Drug classes defined by psychological effects</a>
<a href='/wiki/Category:Drugs_by_psychological_effects' title='Category:Drugs by psychological effects'>Drugs by psychological effects</a>
<a href='/wiki/Category:Psychoactive_drugs' title='Category:Psychoactive drugs'>Psychoactive drugs</a>


  1. Milgram, Norton W.; Callahan, Heather; Siwak, Christina (2006). "Adrafinil: A Novel Vigilance Promoting Agent". CNS Drug Reviews. 5 (3): 193–212. doi:10.1111/j.1527-3458.1999.tb00100.x. ISSN 1080-563X.
  2. "Provigil: Prescribing information" (PDF). United States Food and Drug Administration. Cephalon, Inc. January 2015. Retrieved 16 August 2015.
  3. "Nuvigil: Prescribing information" (PDF). United States Food and Drug Administration. Cephalon, Inc. April 2015. Retrieved 16 August 2015.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.